Stem-Cell Research
Ultraviolet light facilitates better transduction of bone marrow stem cells
Published in Blood Weekly, February 12th, 2004
"Deficiencies in skeletal tissue repair and regeneration lead to conditions like osteoarthritis, osteoporosis and degenerative disc disease. While no cure for these conditions is available, the use of human bone marrow derived-mesenchymal stem cells (HuMSCs) has been shown to have potential for cell-based therapy. Furthermore, recombinant adeno-associated viruses (rAAV) could be used together with HuMSCs for in vivo or ex vivo gene therapy," researchers in the United States report.
"Unfortunately, the poor transduction efficiency of these cells remains a significant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-02-12)
More Articles from Blood Weekly
- Stem-Cell Transplantation
Risedronate prevents bone loss in allo-SCT survivors - Bloodstream Infections
Once-weekly Dalbavancin shows superiority for bloodstream infections in study - Bone Fractures
Bone graft clinical trial initiated at lead U.S. site - Bone Grafts
Further studies of transplanted composite bone grafts-implants are needed - Bone Marrow Transplant
Researchers discover secret for recalling stem cells - Cancer Incidence
Exposure to high levels of trichloroethylene may be increase risk of NHL - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
